Cervical mucus thinning and release during the female reproductive cycle is thought to rely mainly on fluid secretion. However, we now find that mucus released from the murine reproductive tract critically depends upon concurrent bicarbonate (HCO 3 − ) secretion. Prostaglandin E 2 (PGE 2 )-and carbachol-stimulated mucus release was severely inhibited in the absence of serosal HCO 3 − , HCO 3 − transport, or functional cystic fibrosis transmembrane conductance regulator (CFTR). In contrast to mucus release, PGE 2 -and carbachol-stimulated fluid secretion was not dependent on bicarbonate or on CFTR, but was completely blocked by niflumic acid. We found stimulated mucus release was severely impaired in the cystic fibrosis F508 reproductive tract, even though stimulated fluid secretion was preserved. Thus, CFTR mutations and/or poor bicarbonate secretion may be associated with reduced female fertility associated with abnormal mucus and specifically, may account for the increased viscosity and lack of cyclical changes in cervical mucus long noted in women with cystic fibrosis.
Introduction
Changes in cervical mucus properties and bicarbonate (HCO 3 − ) secretion within the female reproductive tract are critically linked to fertility. A HCO 3 − -rich alkaline pH environment is crucial for optimal sperm motility (Muschat, 1926) and capacitation (Wang et al. 2003; Chan et al. 2006 Chan et al. , 2009 . Both HCO 3 − and mucus change dramatically throughout the menstrual cycle, with concentrations of HCO 3 − varying from 35 mM at the follicular phase to at least 90 mM at ovulation (Maas et al. 1977) , which corresponds to the minimum in mucus viscosity (Blair et al. 1941) .
Bicarbonate douching is reported to improve cervical mucus viscoelasticity and improve sperm penetration (Ansari et al. 1980; Everhardt et al. 1990) , and this suggests that HCO 3 − itself may have an important influence on the properties of mucus. The abnormalities of generalized thick mucus and defects in HCO 3 − secretion in the genetic disease cystic fibrosis (CF) also suggest that HCO 3 − may be a critical determinant of mucus properties. More specifically, CF is characterized by pathologies resulting from mucus obstructions in almost all affected organs including the pancreas (Farber et al. 1943; Zuelzer & Newton, 1949) , small intestine (Eggermont, 1996) , hepatobiliary tree (Bhaskar et al. 1998) , small airways (Burgel et al. 2007 ) and salivary and most other exocrine glands (Gugler et al. 1967; Oppenheimer & Esterly, 1975) . The sweat gland, which secretes virtually no mucus, is an exception (Johansen et al. 1968; Quinton, 1999) . Along with a loss of Cl − conductance (Quinton, 1983) , mutations of the cystic fibrosis transmembrane conductance regulator (CFTR) Cl − channel protein also impede HCO 3 − transport, the extent of which appears to correlate with the severity of the CF phenotype (Kopelman et al. 1989; Choi et al. 2001; Quinton, 2001; Reddy & Quinton, 2003) .
Mucus pathology and reproductive physiology intersect in CF women where cervical mucus thinning is absent (Kopito et al. 1973a) , fertility is reduced (Hilman et al. 1996; Edenborough et al. 2000) and cervical mucus plugs may develop (Oppenheimer et al. 1970) . HCO 3 − transport is characteristically impaired in CF affected organs (Kopelman et al. 1988; Smith & Welsh, 1992; Seidler et al. 1997; Clarke & Harline, 1998; Pratha et al. 2000; Choi et al. 2001; Quinton, 2001; Ishiguro et al. 2009 ); consequently, it J Physiol 588.13 seems highly possible that the thick and tenacious cervical mucus of women with CF involves impaired HCO 3 − secretion. We therefore investigated the effect of altering bicarbonate and fluid secretion on stimulated mucus release in the reproductive tracts of wild type (WT) and homozygous F508 CF female mice ex vivo. We describe a new role for HCO 3 − in mucus release, where it seems likely to be critical for normal mucin expansion and transport.
Methods

Ethical information
The University of California San Diego institutional animal care and use committee approved all procedures used in this study. All our studies comply with the policies and regulations of The Journal of Physiology (Drummond, 2009 ).
Animals
WT adult C57BL/6 mice were either purchased from Harlan Laboratories Inc. or taken from our own breeding colony and maintained on standard laboratory chow. The mice were allowed free access to food and water until surgery. The F508 mice were obtained from Case Western Reserve University and were generated by targeted replacement of the WT exon 10 allele with the F508 mutant allele (Zeiher et al. 1995) . To increase survival, the F508 mice were maintained on an osmotic laxative containing electrolytes and polyethylene glycol 3350 (GoLYTELY; Braintree Laboratories, Inc., Braintree, MA, USA) administered ad libitum in the drinking water (Clarke et al. 1996) and a liquid diet of Peptamen Af (Nestlé HealthCare Nutrition, Minnetonka, MN, USA). Mice were used at the oestrous stage of the reproductive cycle, which was determined by the presence of round nucleated epithelial cells, cornified cells and leukocytes obtained from a wet vaginal smear.
The mice were anaesthetized with ketamine (100 mg kg −1 ) and xylazine (10 mg kg −1 ) administered subcutaneously. Once the hindlimb flexor withdrawal reflex ceased, the reproductive tract was excised intact, and the animals were killed immediately by cervical dislocation.
Materials
All chemicals and drugs used were purchased from Sigma-Aldrich (St Louis, MO, USA) with the exception of GlyH-101 (Muanprasat et al. 2004) and MalH-1 (Sonawane et al. 2006) , which were gifts from N. D. Sonawane and A. S. Verkman (University of California, San Francisco) and human MUC5B antibodies, which were a gift from J. K. Sheehan and M. Kesimer (University of North Carolina, Chapel Hill). MUC5B-N-terminal and C-terminal antibodies were polyclonal (anti-rabbit), while MUC5B-central domain antibody was monoclonal (anti-mouse). The human MUC5B antibodies appear to react with mouse Muc5b.
All drugs were dissolved in dimethyl sulphoxide (DMSO) with the exception of prostaglandin E 2 (PGE 2 ), which was dissolved in ethyl alcohol, and carbachol, which was dissolved in water. PGE 2 was used at 10 −6 M (Fong & Chan, 1998) and carbachol was used at 10 −5 M for a maximal secretory response (Hammarstrom, 1980 
Tissue preparation and mucus collection
The excised reproductive tract was placed immediately in chilled Ringer solution containing indomethacin (10
to minimize endogenous prostaglandin release during fine dissection and manoeuvres. The reproductive tracts were mounted vertically with the uterine horn oriented toward the bottom in a custom-built constant temperature chamber. The perfusion chamber was a smaller version of that previously described (Garcia et al. 2009) , adapted by using a 3 ml plastic syringe as the perfusion chamber sealed within a 20 ml plastic syringe with rubber gaskets at each end to form a water jacket (Fig. 1) . 
Mucus analysis
The amount of mucus released was analysed using peroxidase conjugated wheat germ agglutinin-lectin (Triticum vulgare) (lectin) binding of samples loaded onto a polyvinylidene fluoride membrane using a dot blot apparatus. In brief, 200 μl of perfusate samples along with known mucus standards were loaded in triplicate onto the membrane. The membrane was incubated in 3% albumin from bovine serum in Tris-buffered saline (TBS) to block non-specific binding for 2 h, followed by a 2 h incubation in lectin (5 μg ml −1 in TBS) at room temperature. For the MUC5B antibody assay, the membrane was incubated in the primary antibody overnight at 4
• C (1 in 500 dilution), followed by a 1 h incubation in the secondary antibody (1 in 1000 dilution) at room temperature. The membrane was then washed for 30 min in TBS and incubated in 3,3 -diaminobenzidine enhanced liquid substrate for 5 min. For the periodic acid-Schiff (PAS) assay, the membrane was incubated for 10 min in 0.5% periodic acid, followed by 30 min incubation in Schiff's reagent. The intensity of the lectin, PAS and antibody binding was quantified using the density analysis function of Adobe Photoshop.
The mean amount of mucus released after stimulation was normalized as a percentage increase over the basal mucus release (the average value of mucus released 10 min prior to stimulation taken as 100%). See Fig. 2A for a representative trace of mucus release before normalization.
Histology and immunostaining
The horns from freshly isolated uteri were separated for use as matched pairs. Each horn was stimulated with PGE 2 and carbachol for 20 min, one horn in the presence of HCO 3 − and the other in its absence. The tissue was fixed immediately in methanol-Carnoy's fixative (Johansson et al. 2008) . Paraffin-embedded sections were dewaxed and hydrated. Antigens were retrieved using 10 mM sodium citrate, (pH 6). Sections of 5 μM were stained with PAS/hematoxylin or with an antibody to the central domain of MUC5B labelled with a TRITC-conjugated anti-mouse secondary antibody (sigma). DAPI (Roche) was used to counterstain nuclei. Micrographs were obtained with a spinning disc confocal (BD Carv II) microscope (Zeiss, Axiovert 200).
Fluid secretion measurement
Fluid secreted from the reproductive tract was measured by cannulating a uterine horn of the excised tissue with a fire polished glass capillary (0.28 mm Ø × 3 cm length). The lumen was gently flushed using sodium-free Ringer solution to diminish sodium-dependent fluid absorption. The contralateral horn and the vaginal canal were ligated closed to form a cannulated sac isolated from the external solution. After equilibrating, fluid secreted into the lumen displaced fluid into the capillary cannula. To avoid changes in volume due to spontaneous smooth muscle contractions, nifedipine (10 −6 M) was applied prior to mounting in the basolateral solution to inhibit muscle activity for the duration of the measurement. The rate of fluid secretion was measured by monitoring the displacement of the air/liquid meniscus in the cannulating capillary under a low power microscope. The rate of secretion was determined from the volume of fluid, calculated from the diameter of the capillary multiplied by the displacement of the meniscus in the capillary, divided by the collection interval in minutes.
Figure 1. Mucus collection perfusion system
The excised reproductive tract was mounted vertically in a custom-made water-jacketed chamber, with one uterine horn and the vaginal opening ligated to glass capillary tubes as illustrated. The tissue was maintained at 35 ± 2 • C and bath solutions were constantly bubbled with 100% O 2 or 95% O 2 -5% CO 2 and changed as needed.
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Statistics
Statistical analysis of the data was obtained using repeated measures two-way ANOVA with a Bonferroni post hoc test for analysis of mucus and fluid released under different conditions over a period of time. Data are presented as means ± standard error of the mean, n is the number of experiments (one animal per experiment), and P < 0.05 was taken as significantly different.
Results
Stimulating mucus release
Both the cholinergic agonist carbachol and the prostaglandin PGE 2 stimulate cervical mucus release (Hammarstrom, 1980; Duchens et al. 1993) . Initial experiments established that both PGE 2 (10
(maximal mucus release after 5 min = 230 ± 38%; n = 5) and carbachol (10 −5 M) (289 ± 116%; n = 5) stimulated an acute mucus release within 5 min of applying the agonists ( Fig. 2B and C) . The agonists appeared to act synergistically when added together (800 ± 239%; n = 6) ( Fig. 2B and C) . Since maximal mucus release occurred when both agonists were added simultaneously, tissues were stimulated with both carbachol and PGE 2 in all subsequent protocols. After the initial peak, the rate of mucus release returned to modestly above basal, but continuously decreased to pre-stimulus levels ( Fig. 2A and B).
Assay validation
To confirm that the lectin used for assays was binding predominantly to mucins secreted in the reproductive Figure 2 . PGE 2 and carbachol stimulate mucus release A, an example of stimulated mucus release (μg ml −1 g −1 tissue) in response to PGE 2 (10 −6 M) and carbachol (10 −5 M) illustrating the spontaneous rate of release of mucus 10 min prior to stimulation and the peak rate of release that occurs within 5 min of stimulation at time = 0. B, mean rates of mucus release stimulated by the presence of PGE 2 or carbachol or both combined and normalized to percentage increases over pre-stimulation spontaneous rates. C, summary of means of normalized maximal mucus release within 5 min after stimulation with PGE 2 (n = 5), carbachol (n = 5) and both drugs combined (n = 6; * * * P < 0.001, means ± S.E.M.). D, correlation of lectin binding with periodic acid Schiff (PAS) assay and MUC5B antibody binding to the same samples collected after stimulation with PGE 2 and carbachol.
tract, we compared the binding of lectin, PAS and three MUC5B antibodies in the samples collected after stimulation with PGE 2 and Carbachol. In assays of the same samples, the amount of lectin binding correlated well with both the intensity of PAS staining and the amount of MUC5B antibody binding (Fig. 2D) . We took these results as confirmatory evidence that lectin binding gives a good measure of mucus released in this preparation. Since the assay is efficient and economical, we used lectin binding to determine the amounts of mucus released in the samples of all collected perfusates.
Mucus release requires HCO 3
− and CFTR Addition of PGE 2 and carbachol stimulated mucus release into the perfusate by about 8-fold over baseline ( Fig. 2A) . In the absence of HCO 3 − in the bathing medium (Fig. 3A) or in the presence of 4,4 -diisothiocyanatostilbene-2,2 -disulfonic acid (DIDS; 10 −4 M) ( Fig. 3B ) to inhibit the Na + /HCO 3 − cotransporter (NBC) (Romero et al. 1997) , stimulated mucus release did not increase significantly above basal rates (104 ± 15%, n = 4 and 108 ± 30%, n = 4, respectively). While CFTR is best known for its role in Cl − transport in fluid secretion and salt absorption, it is also well known to support HCO 3 − secretion (Clarke & Harline, 1998; Choi et al. 2001; Welsh & Smith, 2001; Ishiguro et al. 2009 ). To determine if CFTR might be required for HCO 3 − secreted during mucus release, we applied GlyH-101 (2 × 10
and MalH-1 (10 −5 M) to inhibit CFTR (Sonawane et al. 2006) . The inhibitors were combined and added 15 min prior to stimulation to both the basolateral and the luminal solutions. Since MalH-1 is cell impermeant and unlikely to access the recessed gland lumens, it seems most likely that most of the effect would be due to the permeant GlyH-101 form of the CFTR inhibitor. Nonetheless, for efficiency, we added MalH-1 to the luminal bath to inhibit accessible surfaces and achieve maximal effect.
Stimulated mucus release was inhibited (99 ± 29%; n = 4; P < 0.001) (Fig. 3C) suggesting CFTR is involved − , PGE 2 + carbachol did not stimulate mucus release (n = 4). B, likewise in the presence of DIDS (10 −4 M, basolateral; n = 4) to inhibit HCO 3 − transport, mucus release was inhibited. C, stimulated mucus release was essentially absent in homozygous CFTR defective ( F508 mutation) mice (n = 4) or when GlyH-101 (2 × 10 −5 M) and MalH-1 (10 −5 M) were both added concurrently to luminal and basolateral solutions to inhibit CFTR function (n = 4). D, summary and comparison of maximal PGE 2 + carbachol-stimulated mucus release after 5 min for A-C compared to control (Fig. 1C ) ( * * * P < 0.001; means ± S.E.M.). Muanprasat et al. 2004; Caputo et al. 2008) , we tested mucus release in homozygous CF F508 mice where mutant CFTR is dysfunctional. Stimulated mucus release was also significantly depressed even though the tissues were bathed in HCO 3 − replete Ringer solution (106 ± 50%; n = 4; P < 0.001) (Fig. 3C and D) .
J Physiol
588.13 in mucus release. However, as the inhibitors may affect other Cl − channels (
Does mucus release require fluid secretion?
Mucus release is often, if not always, accompanied by fluid secretion (Nadel et al. 1979; Joo et al. 2001) . Thus, simultaneous addition of carbachol and PGE 2 may stimulate mucus release that is dependent on fluid secretion. To show that fluid secretion and mucus release occur concurrently, we monitored fluid secretion from native, cannulated reproductive tracts. Spontaneous fluid secretion was measured for 25 min prior to addition of PGE 2 and carbachol and ranged between 0.30 and 1.15 μl min −1 g −1 , 5 min prior to stimulation. PGE 2 (4.5 ± 1.9 μl min
and carbachol (12.2 ± 4.9 μl min −1 g −1 ; n = 5) each stimulated fluid secretion but with a maximal effect when added simultaneously (17.9 ± 3.6 μl min −1 g −1 ; n = 10) (Fig. 4A) . The stimulated fluid secretory response coincided closely with that of mucus released as measured in other tissues (compare Fig. 4A to Fig. 2) .
To determine whether mucus release was dependent on fluid secretion, we measured stimulated mucus release in the presence of bumetanide, which inhibits fluid secretion by virtue of its selective inhibition of the Na + -K + -2Cl − cotransporter (NKCC). Bumetanide (10 −4 M) added to the bath solution almost completely blocked fluid secretion (2.1 ± 1.0 μl min −1 g −1 ; n = 4; P < 0.001) (Fig. 4B and C) and also prevented stimulated mucus release into the perfusate (95 ± 31%; n = 4) (Fig. 4D) .
Is fluid secretion HCO 3
− dependent?
Since blocking fluid secretion clearly impaired mucus release (Fig. 4D) , and since HCO 3 − may enhance fluid transport (Cremaschi et al. 1979; Heintze et al. 1981) , we sought to determine whether the HCO 3 − -dependent mucus release observed here might be due to a reduced HCO 3 − -dependent fluid secretion. However, we found that in contrast to mucus release, PGE 2 and carbachol-stimulated fluid secretion was not significantly different in the presence or absence of HCO 3 − (17.5 ± 6.0 μl min −1 g −1 ; n = 4; P = 0.84) (Fig. 5A and C) or in the presence of basolateral DIDS (12.1 ± 0.86 μl min −1 g −1 ; n = 4; P = 0.27) ( Fig. 5B  and C) .
Fluid secretion does not require CFTR
We also found that mucus release was severely impaired both in tissues from homozygous F508 mice, and in tissues from WT mice whose CFTR function was inhibited. Since some forms of fluid secretion depend on CFTR (Sato & Sato, 1984; Ianowski et al. 2008) , these results raised the question of whether the impaired mucus release is due to a loss of CFTR-dependent fluid secretion. We found that fluid secretion stimulated in the presence of GlyH-101 and MalH-1 was not significantly reduced (21.7 ± 5.1 μl min −1 g −1 ; n = 6; P = 0.68) (Fig. 6A and C) . Corroborating these results, PGE 2 and carbachol-stimulated fluid secretion in the F508 mouse reproductive tract was not significantly different from fluid secretion in WT tissue either (16.3 ± 4.3 μl min −1 g −1 ; n = 4; P = 0.69) ( Fig. 6A and  C) . On the other hand, niflumic acid (10 −4 M) effectively inhibited fluid secretion (0.24 ± 0.12 μl min −1 g −1 ; n = 4; P < 0.001) (Fig. 6B and C) . Although the simplest interpretation of this niflumic acid effect is that fluid secretion is mediated through a Ca 2+ -activated Cl − channel (CaCC) (White & Aylwin, 1990) , niflumic acid also affects other Cl − transporters such as Cl − /HCO 3 − exchangers (Cousin & Motais, 1979 ) and CFTR (Scott-Ward et al. 2004) . However the lack of effect of GlyH-101, which is reported to at least partially block CaCC at high concentrations (Caputo et al. 2008) , raises the possibility that an alternative Cl − channel may support fluid secretion under these conditions.
Mucus is retained in the cervico-uterine glands in the absence of HCO 3
−
Tissue was prepared for histological analysis in an attempt to determine the deposition of mucus after stimulation. PAS and MUC5B antibody micrographs of PGE 2 and carbachol stimulated tissue show that in the presence of HCO 3 − , uterine glands appear to retain only relatively small amounts of mucus ( Fig. 7A and B) , whereas in the absence of HCO 3 − , the uterine glands were largely filled with a PAS positive substance that also correlated with MUC5B labelling ( Fig. 7C and D) .
Discussion
Our working hypothesis is that HCO 3 − is critical for mucus release in the female reproductive tract. A role of HCO 3 − in the release and expansion of mucins into the lumens of exocrine organs has recently been proposed (Quinton, 2008; Garcia et al. 2009 ). The present study demonstrates that HCO 3 − is critical for mucus release in the female reproductive tract, where HCO 3 − and mucus normally change concurrently, with a peak in HCO 3 
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secretion corresponding with a decrease in mucus viscosity (Blandau et al. 1958; Kopito et al. 1973b; Maas et al. 1977) . The results presented here in addition to those observed in the intestine (Garcia et al. 2009 ) support the notion that the hypothesis may hold for gel forming mucin release in general, and not necessarily be a tissue specific phenomenon.
Figure 6. Fluid secretion does not require CFTR and is inhibited by niflumic acid
A, in the presence of HCO 3 − , stimulated fluid secretion was not significantly different in the presence of combined CFTR inhibitors GlyH-101 (2 × 10 −5 M) and MalH-1 (10 −5 M) (P = 0.68; n = 6) or in tissues from F508 mice (P = 0.69; n = 4). B, in the presence of HCO 3 − , niflumic acid (10 −4 M) in the luminal and basolateral solution abolished fluid secretion (P < 0.001; n = 4). C, summary of maximal PGE 2 + carbachol-stimulated fluid secretion rates after 5 min (ns, not significant; * * * P < 0.01 compare to Fig. 3A) . Data shown are means ± S.E.M.
Implications for fertility
Cervical mucus volume in the female reproductive tract increases dramatically during the menstrual cycle with maximal amounts seen at ovulation (Long & Evans, 1922 ). An increase in the water content is thought to be the principal factor contributing to cyclical changes in cervical mucus properties (Katz et al. 1997; Kopito et al. 1973b) . Biochemical changes in cervical mucins, such as dramatic changes in O-glycosylation at ovulation may also contribute to the changes in the physical properties of cervical mucins, as well as promote sperm penetration due to low sialic acid content (Andersch-Bjorkman et al. 2007 ).
Bicarbonate has also been shown to be critical for improving mucus viscoelastic properties (Everhardt et al. 1990) , and our results here demonstrate its importance for normal mucin release. Specifically, a loss of bicarbonate secretion may underlie an absence of cyclical cervical mucus thinning in CF women at ovulation. In addition to a loss of sperm capacitation in the absence of HCO 3 − (Wang et al. 2003) , mucus that retains increased viscosity throughout the reproductive cycle is likely to be a significant impediment to sperm mobility (Steinberg, 1955; Kopito et al. 1973a; Sher & Katz, 1976; Scott et al. 1977) .
Although the factors involved in infertility in CF women are often multifactorial, (Johannesson et al. 1998; Timmreck et al. 2003; Wang et al. 2003; Hodges et al. 2008) , abnormal mucus has long been associated with infertility (Scott et al. 1977; Daunter & Khoo, 1984; Punnonen et al. 1984) . Therefore the effects of poor HCO 3 − secretion on mucus release may be an unappreciated factor in low fertility associated with abnormal mucus in general and specifically in women with CF (Oppenheimer et al. 1970) . In view of the fact that Young's syndrome and conditions of congenital bilateral absence of the vas deferens (CBAVD) are associated with mutations in the CFTR gene (Chillon et al. 1995) , it is tempting to consider that some cases of reduced fertility in females might be associated with putative mild mutations in this gene with a consequence of abnormal cervico-uterine mucus release due to inadequate HCO 3 − secretion. An example of this might be the case of two infertile sisters with significantly abnormal cervical mucus who were found to be compound heterozygote carriers of the cystic fibrosis F508 and R117H/7T mutations (Schoyer et al. 2008) .
Lectin-binding assays mucus
Due to the complex biophysical and biochemical nature of mucus, routine quantification can require extensive sample preparation and time consuming techniques. Lectin binding assays have been developed as an alternative efficient method to assay for these large molecules as a general class (Rhodes & Ching, 1993) . Lectins are carbohydrate-binding proteins that bind selectively and non-covalently to a specific sugar sequence in oligosaccharides and glycoconjugates. Analysis of the O-linked carbohydrate chains in purified cervical secretions collected midcycle revealed high levels of galactose, N -acetylglucosamine, fucose and neuraminic acid (Yurewicz & Moghissi, 1981) . We therefore used wheat germ agglutinin lectin in this study, which is specific for N -acetylglucosamine and neuraminic acid (Gravel, 2002) . We demonstrated that lectin binding correlates well with the binding of three different MUC5B antibodies and to PAS stain, a well established assay for polysaccharides (Kirkeby et al. 1992) (Fig. 2D) . The binding of other lectins such as peanut agglutinin lectin and Erythrinal cristagalli lectin to cervical secretions is also known to correlate with binding of MUC5B in cervical mucus (Argueso et al. 2002) . Therefore, although not a direct measure of mucus secretion, the use of the lectin-binding assay to semi-quantitatively determine the amount of mucus released from the reproductive tract seems well justified.
Independent impacts of HCO 3
− and fluid secretion
Neither the changes in viscoelasticity of mucus in the normal menstrual cycle nor the cause of the thick aggregated mucus associated with CF are well explained. Both have been commonly attributed to mucus hydration, i.e. water content. The concept of dehydrated mucus due to hyperabsorption through the epithelial sodium channel (ENaC) (Boucher, 2007) has been widely accepted for CF airways; however, hyperabsorption does not seem to explain mucus aggregation in organs where there are no known mechanisms of fluid absorption, such as the pancreas (Novak & Hansen, 2002) . The data presented here show that stimulated mucus release in the female reproductive tract is highly dependent on HCO 3 − secretion. In the CF F508 reproductive tract, stimulated mucus release was severely impaired in the presence of basolateral HCO 3 − , suggesting transport of HCO 3 − into the lumen and consequently mucus release depends on CFTR. It is feasible that addition of HCO 3 − to the luminal side would rescue mucus release; however, the complex morphology of the reproductive tract would likely prevent HCO 3 − from reaching the site of mucus release by diffusion. In addition, the secretory flow out of the gland would likely prevent HCO 3 − from interacting with mucins as they are secreted, and in a similar manner to that in the small intestine (Garcia et al. 2009 ) in sufficient to rescue mucus release.
Although fluid secretion is clearly important for mucus release, fluid secretion in the CF F508 reproductive tract was preserved, whereas mucus release was severely impaired. Moreover, removing HCO 3 − did not significantly impair fluid secretion in WT mice, indicating that the reduction in stimulated mucus release is not due to impaired HCO 3 − dependent fluid secretion. These results support the notion that the loss of CFTR-dependent HCO 3 − secretion per se is the principal factor contributing to impaired mucus release rather than to the simple loss of cAMP mediated CFTR-dependent fluid secretion or to the loss of HCO 3 − -dependent fluid secretion. It is noteworthy that these results are not tissue specific and that similar results were recently reported in the small intestine (Garcia et al. 2009 ). HCO 3 − in the reproductive tract appears to thin mucus (Ansari et al. 1980; Everhardt et al. 1990 ) and in CF the loss of HCO 3 − secretion appears to coincide with abnormally thick mucus in affected organs. Together, these observations implicate a crucial role for HCO 3 − in releasing gel forming mucins in general, but how?
Proposed impact of bicarbonate on mucus
Mucins, the essential components of mucus, are extremely large, negatively charged linear polymers of glycoprotein molecules that are packaged in a highly condensed state in intracellular mucus granules. As proposed by Verdugo et al. (1987) , in order for these enormous molecules with their dense population of fixed negative sites to be stored in a highly condensed form, the repulsive forces between the anionic charges must be 'shielded' electrostatically by cations, namely high concentrations of intragranular Ca 2+ and H + . However, once released from the cell, the shielding cations must be extracted to allow the repulsive electronegative forces to expand the polymer rapidly (decondensation) (Verdugo et al. 1987) into an extracellular network of 'tangled strings' (Lee et al. 1977) . In the process the molecular volume increases by as much as 1000-fold in less than a couple of seconds (Verdugo, 1990) . Recently, we proposed that the presence of extracellular HCO 3 − (and CO 3 2− ), which readily complexes with Ca 2+ and protons, appears to be critical for extracting the 'cationic shields' from mucin anions upon exocytosis of the granule (Fig. 8) (Quinton, 2008; Garcia et al. 2009 ). Once unshielded, the repulsive electrostatic forces of exposed anionic sites not only expand the mucin molecules, but also result in a very low coefficient of friction between the expanded gel mucin molecules and the intrinsic mucins of the apical membrane of epithelial cells (Pettersson & Dedinaite, 2008) . We surmise that this loose association between mucins is required to efficiently promote their movement from within the crypts of the cervico-uterine epithelium, the lumens of the mucus glands, and into the cervico-uterine tract.
HCO 3 − seems most likely to be involved extracellularly, where exocytosed mucins would be immediately exposed to high concentrations of HCO 3 − as opposed to an intracellular role in processes that lead up to exocytosis. De Lisle suggested that the effect of HCO 3 − may arise intracellularly with HCO 3 − entering goblet cells from neighbouring cells through gap junctions and then into mucin granules (De Lisle, 2009) or alternatively by HCO 3 − uptake into mucus cells upon stimulation. A gap junction route of entry would require that HCO 3 − be directed passively through adjacent epithelial cells through gap junctions into the mucus cell. Such a mechanism would seem to limit the amount of HCO 3 − that could be rapidly delivered for mucus expansion and would seem to at least require a large accumulation of HCO 3 − in the adjacent cells and/or a significant depolarization of the mucus cell relative to the adjacent cells. However, bestrophin Cl − channels are highly permeable to HCO 3 − (Qu & Hartzell, 2008) , and have recently been shown to be expressed in goblet cells (Yu et al. 2010) , which potentially could provide entry to HCO 3 − . On the other hand, fluid-secreting epithelia can actively transport large quantities of HCO 3 − into luminal spaces into which mucins are released (Trout et al. 1998; Joo et al. 2001; Simpson et al. 2005; Kreindler et al. 2009 ). In this case, the amount of HCO 3 − delivery would be limited only by the number and secretory capacity of these cells forming the epithelial compartment, where it is conceivable that the bicarbonate concentration could be increased several fold above interstitial fluid levels. We note that goblet cells are generally single cells surrounded by putative fluid transporting epithelial cells.
Recent work on the mechanism by which MUC5B mucin is released from granules of salivary cells (Kesimer et al. 2009 ) suggests the process of mucin unravelling may occur in more than one phase, with the initial phase involving the removal of Ca 2+ from the negatively charged oligosaccharides of the mucin core that permits initial expansion followed by a second phase that requires freeing the terminal, poorly glycosylated protein regions of the mucins from nodes. The protein regions appear to be more tightly bound by covalent bonds and/or possibly by strong Ca 2+ binding. HCO 3 − (CO 3 2− ) could be crucial to this phase as well to (1) sequester tightly bound Ca 2+ from protein binding sites in the binding nodes, (2) simply help initial expansion of the packed oligosaccharide cores sufficiently to allow access to the nodal binding sites for enzymatic cleavage that permits the mucin molecule to further unravel, (3) maintain an optimal pH for enzymatic cleavage of intramolecular bonds, or (4) serve as a possible cofactor in the process (Fig. 8) (Quinton, 2009 Mucus release in the presence of HCO 3 − was 8-fold higher than in its absence. Since the reproductive tract was perfused continuously, why was mucus not released into the perfusate even if it remained poorly unexpanded in the absence of HCO 3 − ? It is unlikely that the tissue was unresponsive under these conditions since under these same conditions (no HCO 3 − ), a robust fluid secretory response was present, demonstrating that the tissue was both viable and responsive. Histology of the reproductive tract stimulated in the presence and absence of HCO 3 − demonstrated that without HCO 3 − mucus is stuck in the cervico-uterine glands, apparently unavailable for ready transport through the lumens of the tissue (Fig. 7) . Thus, the luminal perfusate contained significantly less mucus when the tissue was deprived of secreted HCO 3 − . But why is the mucus trapped? Without HCO 3 − , it is possible that Ca 2+ and H + cations are not efficiently extracted and remain associated with mucin molecules. They may increase intra-as well as intermolecular interactions (due to divalent Ca 2+ bridges, hydrogen bonds and electrostatic interactions). If these interactions involve molecules of the intrinsic mucin layer, which are tethered to the membrane lining the lumen of glands (Johansson et al. 2008) , the complete release of the gel-forming mucins should be suppressed and their transport into the luminal perfusate impeded. Interestingly, CFTR is highly expressed in the uterine glands at the oestrous stage of the cycle (Chan et al. 2002) , which is when maximum mucus release occurs. Our data demonstrate mucus release depends on CFTR, and in the absence of HCO 3 − mucus remains stuck in the glands; strongly suggesting a critical role for CFTR mediated HCO 3 − transport in mucus 'transportability' . The data presented here do not prove that a lack of bicarbonate prevents unravelling of mucin molecules, but the results reported here are consistent with results in the small intestine (Garcia et al. 2009) , so that whatever the role of HCO 3 − in normal mucin release, it appears to be fundamental to the process and not tissue specific.
Figure 8. Proposed roles for bicarbonate in mucus release
Highly condensed polyanionic macromolecular mucins are packaged within granules by virtue of high intragranular concentrations of Ca 2+ and H + that shield negatively charged sites on mucins from electrostatic repulsion. Removing these cations from mucins immediately upon release from the cell (by sequestering Ca 2+ or buffering H + ) is essential to allow the negative electrostatic forces of the mucin anions to rapidly expand the condensed mucins into extremely long extended linear polymers that form mucus (right side). Extracellular HCO 3 − appears to be the simplest, most available means to efficiently remove the shielding cations from mucins for optimal expansion. In the absence of HCO 3 − , as likely occurs in CF, inadequate unshielding apparently results in poorly expanded, tenacious and viscous mucus that is difficult to liberate from the epithelial surfaces (Quinton, 2008; Garcia et al. 2009 ). Still, HCO 3 − might also be critical in enhancing the initial expansion of the mucin molecule to allow other factors (enzymes) access to aggregated nodes of protein domains that must be freed to complete the process (left side) (Kesimer et al. 2009; Quinton, 2009) , and may also play a role in creating a local environment that enhances expansion and unravelling by creating a pH for optimal enzymatic activities that cleave intramolecular covalent crosslinks (I. Carlstedt, personal communication).
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Conclusion
HCO 3
− is required for normal release of gel-forming mucins to form transportable mucus in the female reproductive tract. Poor HCO 3 − secretion seems likely to be a component in cases of low fertility as well as in reduced fertility in women with cystic fibrosis specifically. This novel role for HCO 3 − in mucus release should be relevant in other mucus producing organs as well, where gel forming mucins are crucial to numerous physiological functions.
